• 1
    Meloen RH, Turkstra JA, Lankhof H, Puijk WC, Schaaper WM, Dijkstra G, Wensing CJ, Oonk RB. Efficient immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like peptide [published erratum appears in Vaccine 1994; 12:1152]. Vaccine 1994; 12:7416.
  • 2
    Beekman NJ, Schaaper WM, Turkstra JA, Meloen RH. Highly immunogenic and fully synthetic peptide-carrier constructs targetting GnRH. Vaccine 1999; 17:204350.DOI: 10.1016/S0264-410X(98)00407-1
  • 3
    Zeng W, Jackson DC, Murray J, Rose K, Brown LE. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens. Vaccine 2000; 18:10319.DOI: 10.1016/S0264-410X(99)00346-1
  • 4
    Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, Jackson DC, Good MF. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med 2000; 6:4559.DOI: 10.1038/74719
  • 5
    Herzenberg LA & Tokuhisa T. Carrier-priming leads to hapten-specific suppression. Nature 1980; 285:6647.
  • 6
    Schutze MP, Leclerc C, Jolivet M, Audibert F, Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J Immunol 1985; 135:231922.
  • 7
    Su H, Morrison RP, Watkins NG, Caldwell HD. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med 1990; 172:20312.
  • 8
    Williams KM, Bigley EC, Raybourne RB. Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides. Infect Immun 2000; 68:253545.
  • 9
    Levely ME, Bannow CA, Smith CW, Nicholas JA. Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes. J Virol 1991; 65:378996.
  • 10
    Mustafa AS, Shaban FA, Abal AT, Al-Attiyah R, Wiker HG, Lundin KE, Oftung F, Huygen K. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines. Infect Immun 2000; 68:393340.
  • 11
    Russell-Jones GJ, Sullivan JS, Geczy AF. Peptide sequences with strong stimulatory activity for lymphoid cells: implications for vaccine development. Vaccine 1993; 11:13105.
  • 12
    Rimmelzwaan GF, Poelen MC, Meloen RH, Carlson J, UytdeHaag FG, Osterhaus AD. Delineation of canine parvovirus T cell epitopes with peripheral blood mononuclear cells and T cell clones from immunized dogs. J Gen Virol 1990; 71:23219.
  • 13
    Vandevelde M & Zurbriggen A. The neurobiology of canine distemper virus infection. Vet Microbiol 1995; 44:27180.
  • 14
    Barrett T, Clarke DK, Evans SA, Rima BK. The nucleotide sequence of the gene encoding the F protein of canine distemper virus: a comparison of the deduced amino acid sequence with other paramyxoviruses. Virus Res 1987; 8:37386.
  • 15
    Merz DC, Scheid A, Choppin PW. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med 1980; 151:27588.
  • 16
    Graves MC, Silver SM, Choppin PW. Measles virus polypeptides synthesis in infected cells. Virology 1978; 86:25463.
  • 17
    Norrby E, Utter G, Orvell C, Appel MJ. Protection against canine distemper virus in dogs after immunization with isolated fusion protein. J Virol 1986; 58:53641.
  • 18
    Sad S, Chauhan VS, Arunan K, Raghupathy R. Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes. Vaccine 1993; 11:114550.
  • 19
    Obeid OE, Partidos CD, Steward MW. Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus. J Gen Virol 1993; 74:254957.
  • 20
    Fitzmaurice CJ, Brown LE, McInerney TL, Jackson DC. The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants. Vaccine 1996; 14:55360.DOI: 10.1016/0264-410X(95)00217-O
  • 21
    Ghosh S & Jackson DC. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Int Immunol 1999; 11:110310.
  • 22
    Loffler S, Lottspeich F, Lanza F, Azorsa DO, Ter Meulen V, Schneider-Schaulies J. CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol 1997; 71:429.
  • 23
    Brons NH, Blaich A, Wiesmuller KH, Schneider F, Jung G, Muller CP. Hierarchic T-cell help to non-linked B-cell epitopes. Scand J Immunol 1996; 44:47884.
  • 24
    Muller CP, Bunder R, Mayser H et al. Intramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein. Mol Immunol 1995; 32:3747.
  • 25
    Partidos CD & Steward MW. Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J Gen Virol 1990; 71:2099105.
  • 26
    Cherpillod P, Beck K, Zurbriggen A, Wittek R. Sequence analysis and expression of the attachment and fusion proteins of canine distemper virus wild-type strain A75/17. J Virol 1999; 73:22639.